The analysis confirmed that CRP at baseline was associated with an increased risk of type 2 diabetes after adjustment for age, sex, BMI, waist, systolic blood pressure, diastolic blood pressure, and HDL (RRCRP  Q4  versus  Q1: 1.76 (95%CI 1.27, 2.45); Ptrend < .01). The gene discussed is CRP; the disease is type 2 diabetes mellitus.